restructuring
The 5 Largest Biopharma Layoffs of Q1 2025: An Overview of Industry Restructuring
Biopharma layoffs 2025, Novartis layoffs, Galapagos layoffs, Bristol Myers Squibb layoffs, Merck cuts, Gilead workforce reduction, Q1 2025 job cuts, biotech restructuring, pharmaceutical industry job losses, industry trends.
HHS Overhaul: RFK Jr. Cuts 20,000 Jobs in Major Restructuring
Robert F. Kennedy Jr., Department of Health and Human Services (HHS), job cuts, restructuring, Administration for a Healthy America (AHA), chronic disease epidemic, efficiency, cost-saving
Nkarta lays off 3rd of staff, including CFO, to fund autoimmune CAR NK program
Nkarta, restructuring, Allogeneic CD19-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX019, Cell Therapy
Eisai Cuts 121 US Jobs in Strategic Restructuring
Eisai, layoffs, restructuring, US operations, pharmaceutical industry, Leqembi, Alzheimer’s disease
Lava cuts jobs by 30% after key drug discontinued
LAVA Therapeutics, restructuring, workforce reduction, LAVA-1207, discontinuation, mCRPC, LAVA-1266, strategic alternatives, cash runway
Inventiva Slashes Workforce and Pipeline to Focus on MASH Drug Lanifibranor
Inventiva, layoffs, pipeline reduction, lanifibranor, MASH, Phase 3 trial, biotech restructuring
Bristol Myers Squibb Expands Cost-Cutting Measures and Streamlines Pipeline for Future Growth
Bristol Myers Squibb, cost-cutting, pipeline optimization, patent cliff, strategic restructuring, operational efficiency, pharmaceutical industry
Pharmaceutical Giants Bristol Myers Squibb and Kyowa Kirin Announce 119 Layoffs in New Jersey Amid Restructuring Efforts
Bristol Myers Squibb, Kyowa Kirin, layoffs, New Jersey, restructuring, pharmaceutical industry, cost-cutting, workforce reduction
Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance
Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry
Charles River Laboratories Closing Durham Facility, Laying Off 31 Employees
Charles River Laboratories, Durham, North Carolina, facility closure, layoffs, pharmaceutical research, contract research organization, restructuring